Peer review reports
From: Lentinan enhances the antitumor effects of Delta-like 1 via neutrophils
Original Submission | ||
---|---|---|
2 Apr 2022 | Submitted | Original manuscript |
Resubmission - Version 2 | ||
Submitted | Manuscript version 2 | |
11 May 2022 | Reviewed | Reviewer Report |
1 Jun 2022 | Reviewed | Reviewer Report - Ewa Jabłońska |
14 Jun 2022 | Author responded | Author comments - Songbing Qin |
Resubmission - Version 3 | ||
14 Jun 2022 | Submitted | Manuscript version 3 |
16 Jun 2022 | Author responded | Author comments - Songbing Qin |
Resubmission - Version 4 | ||
16 Jun 2022 | Submitted | Manuscript version 4 |
17 Jun 2022 | Author responded | Author comments - Songbing Qin |
Resubmission - Version 5 | ||
17 Jun 2022 | Submitted | Manuscript version 5 |
7 Jul 2022 | Author responded | Author comments - Songbing Qin |
Resubmission - Version 6 | ||
7 Jul 2022 | Submitted | Manuscript version 6 |
13 Jul 2022 | Author responded | Author comments - Songbing Qin |
Resubmission - Version 7 | ||
13 Jul 2022 | Submitted | Manuscript version 7 |
Publishing | ||
18 Aug 2022 | Editorially accepted | |
25 Aug 2022 | Article published | 10.1186/s12885-022-10011-w |